These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 16163171)
1. The role of FDG-PET imaging in the management of lymphoma. Kostakoglu L; Leonard JP; Coleman M; Goldsmith SJ Clin Adv Hematol Oncol; 2004 Feb; 2(2):115-21. PubMed ID: 16163171 [TBL] [Abstract][Full Text] [Related]
2. Fluorine-18 fluorodeoxyglucose positron emission tomography in the staging and follow-up of lymphoma: is it time to shift gears? Kostakoglu L; Goldsmith SJ Eur J Nucl Med; 2000 Oct; 27(10):1564-78. PubMed ID: 11083548 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography in lymphoma: comparison with computed tomography and Gallium-67 single photon emission computed tomography. Kostakoglu L; Goldsmith SJ Clin Lymphoma; 2000 Jun; 1(1):67-74; discussion 75-6. PubMed ID: 11707816 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma. Shen YY; Kao A; Yen RF Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600 [TBL] [Abstract][Full Text] [Related]
5. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma. Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454 [TBL] [Abstract][Full Text] [Related]
6. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification. Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800 [TBL] [Abstract][Full Text] [Related]
7. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison]. Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362 [TBL] [Abstract][Full Text] [Related]
8. Imaging: staging and evaluation of lymphoma using nuclear medicine. Divgi C Semin Oncol; 2005 Feb; 32(1 Suppl 1):S11-8. PubMed ID: 15786021 [TBL] [Abstract][Full Text] [Related]
9. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]. Pichler R; Maschek W; Hatzl-Griesenhofer M; Huber H; Wimmer G; Wahl G; Fridrik M Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408 [TBL] [Abstract][Full Text] [Related]
10. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma. Liu Y Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435 [TBL] [Abstract][Full Text] [Related]
11. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management. Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560 [TBL] [Abstract][Full Text] [Related]
12. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma. Sasaki M; Kuwabara Y; Koga H; Nakagawa M; Chen T; Kaneko K; Hayashi K; Nakamura K; Masuda K Ann Nucl Med; 2002 Jul; 16(5):337-45. PubMed ID: 12230093 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas]. Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637 [TBL] [Abstract][Full Text] [Related]
15. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Isohashi K; Tatsumi M; Higuchi I; Inoue A; Nakajo K; Ishikawa J; Shimosegawa E; Kanakura Y; Nakamura H; Hatazawa J Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558 [TBL] [Abstract][Full Text] [Related]
16. 18F-fluorodeoxyglucose-positron emission tomography in the staging of malignant lymphoma compared with CT and 67Ga scan. Hong SP; Hahn JS; Lee JD; Bae SW; Youn MJ Yonsei Med J; 2003 Oct; 44(5):779-86. PubMed ID: 14584092 [TBL] [Abstract][Full Text] [Related]
17. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
18. [Malignant lymphoma]. Okamoto R Gan To Kagaku Ryoho; 2009 Dec; 36(13):2532-6. PubMed ID: 20009452 [TBL] [Abstract][Full Text] [Related]
19. 18F-FDG-PET/CT in lymphoma: two decades of experience. Alvarez Páez AM; Nogueiras Alonso JM; Serena Puig A Rev Esp Med Nucl Imagen Mol; 2012; 31(6):340-9. PubMed ID: 22841459 [TBL] [Abstract][Full Text] [Related]